Psychedelic Week story critiques proposed legislation sponsored by state Sen. Elizabeth Steiner, D-Portland, which proposes to engage OHSU to analyze the outcomes of psilocybin services. The story alleges that the bill misrepresents the voter-approved service as a medical therapy, as opposed to a service available to consenting adults.

In a video interview with OncLive, Chris Ryan, M.D., discusses the role of adjuvant therapy for patients with renal cell carcinoma.

In a Pharmacy Today story about prolonged stress since the COVID-19 pandemic, Lam Nguyen, Pharm.D., talks about OHSU’s pharmacy department creating part-time positions to reduce workplace stress. He says, “we actually realized ‘why not create five 0.8s?’ This allowed our staff to have more balance in [their] workload, and it’s been well-received.”

Alexander Witkowski, M.D., Ph.D., and Joanna Ludzik, M.D. Ph.D., discuss how to discern rare signs of skin cancer.

A study led by Peter Campbell, M.D., M.P.H., indicates artificial intelligence can infer race from images of the retina, which Campbell says suggest additional steps may be needed to prevent racial bias in AI.

Alice Cuprill-Comas, OHSU executive vice president of institutional affairs and general counsel, is recognized by the Portland Business Journal among 2023 business executives of the year.

U.S. News & World Report released its top 15 medical schools for research, which revealed OHSU as No. 1 for family medicine.

In an article about the Oregon bill on abortion and gender-affirming care, KGW-TV cites an OHSU website, which feature frequently asked questions on the topic.

Women.com suggests the benefits of scheduling sex, citing OHSU Center for Women’s Health guidance regarding the benefits of sex in lowering blood pressure, relieving depression, promoting pain relief and improving sleep.